Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin

Exclusion Criteria

• •Type 1 Diabetes Mellitus
• •Former treated on TZD
• •Pregnancy / Lactation
• •Creatine ≥1.5 mg/dl
• •Hepatic disease, jaundice,or ALT/AST≥ 2.5 times of normal range
• •Hormone therapy,
• •Acute status of Diabetes complications
• •Severe concomitant disease or complications with high risk of unexpected fatal events, like Myocardial Infarct, stroke, heart failure.
• •Allergic to insulin glargine or any ingredient
• •Participation in another clinical trial within 3 months
• •The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.